On the stock market since 2000, it operates in the everyday-essentials business. It has 33 employees. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Average growth of 52% a year over the last 4 years. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: Right now the product sells for less than it costs to make; every sale deepens the loss.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 3 years, sales grew about 49% a year on average.
Sales run at $10.3M a year. A small number, but proof the product has real buyers.
There is $55.1M in the vault; even if every debt were paid off, $52.8M would remain.
A loss of $4.9M against $10.3M in annual sales.
The stock sits at $0.22. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, IMG sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: IMG is a high-risk stock — not yet profitable, and its future rides on its product catching on.